This antibody targets the SLC44A4 antigen and is utilized in the synthesis of the antibody-drug conjugate ASG-5ME. It serves as a key research tool for investigating SLC44A4 in oncology, supporting both in vitro binding studies and in vivo preclinical model research.
Clonality:
Recombinant
Concentration:
6.62 mg/mL
Molecular Weight:
145.99 kDa
Purity:
99.30% (May vary between batches)
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted